Abstract
The rationale of the drug design method is generally focused on the designing of “magic bullets” that acts on individual drug targets. This idea of “one gene, one target, one disease” prejudiced many aspects of drug discovery strategy especially for the complex diseases. Many of the drugs give their pharmacological action by targeting multiple proteins rather than targeting single protein. This phenomenon of designing new leads that target multiple proteins provided new wings in the drug discovery process. Network pharmacology is a system biology-based methodology tool to discover the concept based on “multiple targets, multiple effects, complex diseases.” This methodology helps to discover new entities that act on multiple targets and replaces “magic bullets” by “magic shotguns.” In this chapter, we highlighted importance of network pharmacology method in drug discovery process. With this we also summarized the process of develo** network pharmacology (data collection to network generation), applications, limitations, and future prospective of network pharmacology approaches.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Berdigaliyev N, Aljofan M (2020) An overview of drug discovery and development. Future Med Chem 12(10):939–947. https://doi.org/10.4155/fmc-2019-0307
Breitkreutz D, Hlatky L, Rietman E, Tuszynski JA (2012) Molecular signaling network complexity is correlated with cancer patient survivability. Proc Natl Acad Sci U S A 109(23):9209–9212. https://doi.org/10.1073/pnas.1201416109
Breitling R (2010) What is systems biology? Front Physiol 1:9. https://doi.org/10.3389/fphys.2010.00009
Butcher EC, Berg EL, Kunkel EJ (2004) Systems biology in drug discovery. Nat Biotechnol 22(10):1253–1259. https://doi.org/10.1038/nbt1017
Chen Q, Zhou XJ, Sun F (2015) Finding genetic overlaps among diseases based on ranked gene lists. J Comput Biol 22(2):111–123. https://doi.org/10.1089/cmb.2014.0149
Deng Z, Chen G, Shi Y, Lin Y, Ou J et al (2022) Curcumin and its nano-formulations: defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification. Front Pharmacol 13:920514. https://doi.org/10.3389/fphar.2022.920514
Faratian D, Clyde RG, Crawford JW, Harrison DJ (2009) Systems pathology--taking molecular pathology into a new dimension. Nat Rev Clin Oncol 6(8):455–464. https://doi.org/10.1038/nrclinonc.2009.102
Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK et al (2021) Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers 25(3):1315–1360. https://doi.org/10.1007/s11030-021-10217-3
Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7(8):589–600. https://doi.org/10.1038/nrm1983
Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4(11):682–690. https://doi.org/10.1038/nchembio.118
Huang C, Zheng C, Li Y, Wang Y, Lu A et al (2014) Systems pharmacology in drug discovery and therapeutic insight for herbal medicines. Brief Bioinform 15(5):710–733
Hughes JP, Rees S, Kalindjian SB, Philpott KL (2011) Principles of early drug discovery. Br J Pharmacol 162(6):1239–1249. https://doi.org/10.1111/j.1476-5381.2010.01127.x
Khan SA, Lee TKW (2022) Network-pharmacology-based study on active phytochemicals and molecular mechanism of Cnidium monnieri in treating hepatocellular carcinoma. Int J Mol Sci 23(10). https://doi.org/10.3390/ijms23105400
Kim J, Gao L, Tan K (2012) Multi-analyte network markers for tumor prognosis. PLoS One 7(12):e52973. https://doi.org/10.1371/journal.pone.0052973
Kim SC, Jung Y, Park J, Cho S, Seo C et al (2013) A high-dimensional, deep-sequencing study of lung adenocarcinoma in female never-smokers. PLoS One 8(2):e55596. https://doi.org/10.1371/journal.pone.0055596
Kitano H (2002) Systems biology: a brief overview. Science 295(5560):1662–1664. https://doi.org/10.1126/science.1069492
Li S, Zhang B, Jiang D, Wei Y, Zhang N (2010) Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics 11(Suppl 11):S6. https://doi.org/10.1186/1471-2105-11-s11-s6
Li H, Wang X, Lu X, Zhu H, Li S et al (2019) Co-expression network analysis identified hub genes critical to triglyceride and free fatty acid metabolism as key regulators of age-related vascular dysfunction in mice. Aging (Albany NY) 11(18):7620–7638. https://doi.org/10.18632/aging.102275
Ma’ayan A (2011) Introduction to network analysis in systems biology. Sci Signal 4(190):tr5. https://doi.org/10.1126/scisignal.2001965
Mlecnik B, Galon J, Bindea G (2018) Comprehensive functional analysis of large lists of genes and proteins. J Proteome 171:2–10. https://doi.org/10.1016/j.jprot.2017.03.016
Mohs RC, Greig NH (2017) Drug discovery and development: role of basic biological research. Alzheimers Dement (N Y) 3(4):651–657. https://doi.org/10.1016/j.trci.2017.10.005
Muzio G, O’Bray L, Borgwardt K (2021) Biological network analysis with deep learning. Brief Bioinform 22(2):1515–1530. https://doi.org/10.1093/bib/bbaa257
Nguyen HH, Park J, Kang S, Kim M (2015) Surface plasmon resonance: a versatile technique for biosensor applications. Sensors (Basel) 15(5):10481–10510. https://doi.org/10.3390/s150510481
Noor F, Saleem MH, Aslam MF, Ahmad A, Aslam S (2021) Construction of miRNA-mRNA network for the identification of key biological markers and their associated pathways in IgA nephropathy by employing the integrated bioinformatics analysis. Saudi J Biol Sci 28(9):4938–4945. https://doi.org/10.1016/j.sjbs.2021.06.079
Noor F, Saleem MH, Javed MR, Chen JT, Ashfaq UA et al (2022) Comprehensive computational analysis reveals H5N1 influenza virus-encoded miRNAs and host-specific targets associated with antiviral immune responses and protein binding. PLoS One 17(5):e0263901. https://doi.org/10.1371/journal.pone.0263901
Noor F, Tahir Ul Qamar M, Ashfaq UA, Albutti A, Alwashmi ASS et al (2022a) Network pharmacology approach for medicinal plants: review and assessment. Pharmaceuticals (Basel, Switzerland) 15(5):572. https://doi.org/10.3390/ph15050572
Noor F, Tahir ul Qamar M, Ashfaq UA, Albutti A, Alwashmi ASS et al (2022b) Network pharmacology approach for medicinal plants: review and assessment. Pharmaceuticals 15(5):572
Paik S (2007) Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen. Oncologist 12(6):631–635. https://doi.org/10.1634/theoncologist.12-6-631
Pal SK, Shukla Y (2003) Herbal medicine: current status and the future. Asian Pac J Cancer Prev 4(4):281–288
Pe’er D, Hacohen N (2011) Principles and strategies for develo** network models in cancer. Cell 144(6):864–873. https://doi.org/10.1016/j.cell.2011.03.001
Radpour R, Barekati Z, Kohler C, Schumacher MM, Grussenmeyer T et al (2011) Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment. PLoS One 6(11):e27355. https://doi.org/10.1371/journal.pone.0027355
Rai S, Raj U, Varadwaj PK (2018) Systems biology: a powerful tool for drug development. Curr Top Med Chem 18(20):1745–1754. https://doi.org/10.2174/1568026618666181025113226
Rehman A, Ashfaq UA, Javed MR, Shahid F, Noor F et al (2022) The screening of phytochemicals against NS5 polymerase to treat Zika virus infection: integrated computational based approach. Comb Chem High Throughput Screen 25(4):738–751. https://doi.org/10.2174/1386207324666210712091920
Reimand J, Isserlin R, Voisin V, Kucera M, Tannus-Lopes C et al (2019) Pathway enrichment analysis and visualization of omics data using g:profiler, GSEA, cytoscape and enrichment. Map Nat Protoc 14(2):482–517. https://doi.org/10.1038/s41596-018-0103-9
Romano JD, Tatonetti NP (2019) Informatics and computational methods in natural product drug discovery: a review and perspectives. Front Genet 10:368–368. https://doi.org/10.3389/fgene.2019.00368
Silverman EK, Schmidt HH, Anastasiadou E, Altucci L, Angelini M et al (2020) Molecular networks in Network Medicine: Development and applications. Wiley Interdiscip Rev Syst Biol Med 12(6):e1489
Sun Y, Yang J (2019) A bioinformatics investigation into the pharmacological mechanisms of the effect of Fufang Danshen on pain based on methodologies of network pharmacology. Sci Rep 9(1):5913. https://doi.org/10.1038/s41598-019-40694-4
Szymański P, Markowicz M, Mikiciuk-Olasik E (2012) Adaptation of high-throughput screening in drug discovery-toxicological screening tests. Int J Mol Sci 13(1):427–452. https://doi.org/10.3390/ijms13010427
Tan N, Gwee KA, Tack J, Zhang M, Li Y et al (2020) Herbal medicine in the treatment of functional gastrointestinal disorders: a systematic review with meta-analysis. J Gastroenterol Hepatol 35(4):544–556. https://doi.org/10.1111/jgh.14905
Wang J, **ong X, Feng B (2013) Cardiovascular effects of salvianolic acid B. Evid Based Complement Alternat Med 2013:247948. https://doi.org/10.1155/2013/247948
Wang X, Wang ZY, Zheng JH, Li S (2021) TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches. Chin J Nat Med 19(1):1–11. https://doi.org/10.1016/s1875-5364(21)60001-8
Wu L, Wang Y, Fan X (2011) Tools for network pharmacology study: network visualization and network analysis. Zhongguo Zhong Yao Za Zhi 36(21):2923–2925
Wu CC, D’Argenio D, Asgharzadeh S, Triche T (2012) TARGETgene: a tool for identification of potential therapeutic targets in cancer. PLoS One 7(8):e43305. https://doi.org/10.1371/journal.pone.0043305
**ao Z, Ye Q, Duan X, **ang T (2021) Network pharmacology reveals that resveratrol can alleviate COVID-19-related hyperinflammation. Dis Markers 2021:4129993. https://doi.org/10.1155/2021/4129993
Yang HY, Liu ML, Luo P, Yao XS, Zhou H (2022) Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine. Phytomedicine 104:154268. https://doi.org/10.1016/j.phymed.2022.154268
Zhang Z, Chan DW (2010) The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers. Cancer Epidemiol Biomark Prev 19(12):2995–2999. https://doi.org/10.1158/1055-9965.Epi-10-0580
Zhang GB, Li QY, Chen QL, Su SB (2013) Network pharmacology: a new approach for Chinese herbal medicine research. Evid Based Complement Alternat Med 2013:621423. https://doi.org/10.1155/2013/621423
Zhang R-z, Yu S-j, Bai H, Ning K (2017) TCM-mesh: the database and analytical system for network pharmacology analysis for TCM preparations. Sci Rep 7(1):2821. https://doi.org/10.1038/s41598-017-03039-7
Zhang R, Zhu X, Bai H, Ning K (2019) Network pharmacology databases for traditional Chinese medicine: review and assessment. Front Pharmacol 10:123. https://doi.org/10.3389/fphar.2019.00123
Zhang Q, Liu J, Li R, Zhao R, Zhang M et al (2020a) A network pharmacology approach to investigate the anticancer mechanism and potential active ingredients of Rheum palmatum L. against lung cancer via induction of apoptosis. Front Pharmacol 11:528308. https://doi.org/10.3389/fphar.2020.528308
Zhang X, Shen T, Zhou X, Tang X, Gao R et al (2020b) Network pharmacology based virtual screening of active constituents of Prunella vulgaris L. and the molecular mechanism against breast cancer. Sci Rep 10(1):15730. https://doi.org/10.1038/s41598-020-72797-8
Zhou Z, Chen B, Chen S, Lin M, Chen Y et al (2020) Applications of network pharmacology in traditional Chinese medicine research. Evid Based Complement Alternat Med 2020:1646905. https://doi.org/10.1155/2020/1646905
Zimmermann GR, Lehár J, Keith CT (2007) Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today 12(1–2):34–42. https://doi.org/10.1016/j.drudis.2006.11.008
Zuo HL, Lin YC, Huang HY, Wang X, Tang Y et al (2021) The challenges and opportunities of traditional Chinese medicines against COVID-19: a way out from a network perspective. Acta Pharmacol Sin 42(6):845–847. https://doi.org/10.1038/s41401-021-00645-0
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Shah, A., Patel, V., Jain, M., Parmar, G. (2023). Network Pharmacology and Systems Biology in Drug Discovery. In: Rudrapal, M., Khan, J. (eds) CADD and Informatics in Drug Discovery. Interdisciplinary Biotechnological Advances. Springer, Singapore. https://doi.org/10.1007/978-981-99-1316-9_10
Download citation
DOI: https://doi.org/10.1007/978-981-99-1316-9_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-1315-2
Online ISBN: 978-981-99-1316-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)